<DOC>
	<DOCNO>NCT02865135</DOCNO>
	<brief_summary>This research study study therapeutic vaccine , name DPX-E7 , possible treatment Human Papilloma Virus HPV related head neck , cervical anal cancer ( positive HLA-A*02 ) .</brief_summary>
	<brief_title>Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal , Cervical And Anal Cancer</brief_title>
	<detailed_description>This phase Ib/II clinical trial . DPX-E7 therapeutic vaccine , intend treat HPV-related head neck , cervical anal cancer . DPX-E7 investigational vaccine FDA ( U.S. Food Drug Administration ) approve DPX-E7 vaccine treatment disease . DPX-E7 test human first time . DPX-E7 kind immunotherapy make immune system elicit anti-tumor response generate CD8+ T-cells . CD8+ T-cells play important role fight viral infection Cyclophosphamide use treat various type cancer . It biological modifier drug work slow stop cell growth .</detailed_description>
	<mesh_term>Anus Neoplasms</mesh_term>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Each patient must positive HLAA*02 meet follow inclusion criterion enrol study : Histologically cytologically proven HPVOC cervical cancer anal cancer , base expression HPV type16 immunohistochemistry and/or HPV 16 DNA analysis ISH tumor tissue primary metastatic lesion . Incurable HPVOC , define : Relapsed progressive disease primary site and/or regional lymph node initial treatment ( e.g . Surgery , radiotherapy chemoradiotherapy ) potentially curative option ( i.e . surgery radiation ) ; OR Distant metastasis Incurable cervical anal cancer , define : Relapsed progressive disease primary site and/or regional lymph node initial treatment ( e.g . systemic chemotherapy ) potentially curative option ( i.e . surgery chemoradiotherapy ) . Chemotherapy administer conjunction primary radiation radiosensitizer count systemic chemotherapy regimen ; OR Distant metastasis refractory initial treatment ( least one prior chemotherapeutic regimen include single chemotherapeutic , combination chemotherapeutics , biologic drug bevacizumab ) . Accessible tumor sequential biopsy Terminology Criteria Adverse Events Version 4.0 ( CTCAE v4.03 ) grade 1 good ( except &lt; grade 2 neuropathy , alopecia , xerostomia , dysphagia , mucositis ) ; Age ≥ 18 year ; Measurable disease , accord modify RECIST 1.1 irRECIST ( Appendix B &amp; C ) ; Eastern Cooperative Oncology Group performance status ( ECOG PS ) ≤ 2 ( Appendix A ) Adequate bone marrow , liver renal function , define : Hemoglobin ≥ 10 g/dL ; Absolute neutrophil count ( ANC ) ≥ 1000/μL ; Absolute lymphocyte count ≥ 400/μL ; Platelet count ≥ 100,000/μL ; ALT AST ≤ 2.5 X upper limit normal ( ULN ) ; Total bilirubin ≤ 1.5 X ULN ; Serum creatinine ≤ 1.5 X ULN ; Women childbearing potential ( WOCBP ) must willing use acceptable mean birth control ; Men could potentially father child must also use birth control Signed informed consent Radiotherapy primary HPVOC within 8 week , radiotherapy reason within 3 week prior first dose trial treatment ; Chemotherapy within 3 week prior first dose trial treatment ; Other cancer past 5 year , except carcinoma situ cervix bladder , nonmelanomatous skin cancer ; Inaccessible tumor lack consent sequential biopsy Uncontrolled central nervous system ( CNS ) metastases ( i.e . know CNS lesion radiographically unstable , symptomatic and/or require escalate dos corticosteroid ) ; Active hepatitis , know HIV , condition require immunosuppressive therapy , include current use high dose systemic corticosteroid ; Autoimmune disease , systemic lupus erythematosis rheumatoid arthritis , active require current immunosuppressive therapy ; Active uncontrolled serious infection ; WOCBP positive βhCG test breastfeeding . Acute chronic skin disorder would interfere subcutaneous injection vaccine subsequent assessment potential skin reaction ; Allergies vaccine , discussion Immunovaccine , serious enough warrant exclusion study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>HPV Related Head Neck</keyword>
	<keyword>Cervical</keyword>
	<keyword>Anal Cancer</keyword>
</DOC>